Longitudinal non-interventional observational study on Adherence, safety and tolerability of AVANZ in adults and GRAZAX and SLIToneULTRA in adults and children (5 - 17 years) in patients with allergic Rhinoconjunctivitis in GErmany - LARGE

Trial Profile

Longitudinal non-interventional observational study on Adherence, safety and tolerability of AVANZ in adults and GRAZAX and SLIToneULTRA in adults and children (5 - 17 years) in patients with allergic Rhinoconjunctivitis in GErmany - LARGE

Active, no longer recruiting
Phase of Trial: Phase IV

Latest Information Update: 17 Oct 2017

At a glance

  • Drugs Allergy immunotherapies; Allergy immunotherapies; Grass pollen allergy immunotherapy
  • Indications Allergic rhinitis; Allergic rhinoconjunctivitis
  • Focus Therapeutic Use
  • Acronyms LARGE
  • Sponsors ALK-Abello
  • Most Recent Events

    • 20 Jan 2015 Status changed from recruiting to active, no longer recruiting.
    • 13 Jan 2014 Status changed from not yet recruiting to recruiting, according to German Clinical Trials Register record.
    • 31 Jul 2013 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top